David George
Keine laufenden Positionen mehr
Profil
Mr. David George is Co-Chairman at CellAura Technologies Ltd.
He is on the Board of Directors at L3 Technology Ltd.
Mr. George was previously employed as Chairman by Probe Scientific Ltd., Chief Executive Officer by Glucotronics Ltd., Non-Executive Director by Advanced Medical Services, Inc., a Principal by Boehringer Mannheim Canada Ltd., a Principal by Ciba Corning Diagnostics Corp., a Principal by Flow Laboratories, Inc., and Vice President-Clinical & Critical Care by Chiron Diagnostics Corp.
He also served on the board at Bayer Plc.
Ehemalige bekannte Positionen von David George
| Unternehmen | Position | Ende |
|---|---|---|
L3 Technology Ltd.
 L3 Technology Ltd. Miscellaneous Commercial ServicesCommercial Services L3 Technology Ltd. develops technology for cholesterol testing applications. The firm provides testing system for reading blood analytes from various samples. It offers a lipid profile testing system for measuring a multi-fraction lipid profile from a finger stick sample of blood, serum, or plasma. The company was founded in on June 28, 2001 and is headquartered in Sevenoaks, the United Kingdom. | Direktor/Vorstandsmitglied | - |
| Flow Labss | Corporate Officer/Principal | - |
| Advanced Medical Services, Inc. | Direktor/Vorstandsmitglied | - |
| Ciba Corning Diagnostics Corp. | Corporate Officer/Principal | - |
| Boehringer Mannheim Canada Ltd. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
CellAura Technologies Ltd.
 CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Probe Scientific Ltd.
 Probe Scientific Ltd. Medical DistributorsDistribution Services Probe Scientific Ltd. develops medical devices. The firm offers MicroEye, ContinuMon and NanoEye products. The company was founded by Denis Lonergan and Mark O’Connell in 1998 and is headquartered in Thurleigh, the United Kingdom. | Distribution Services |
| Glucotronics Ltd. | |
Chiron Diagnostics Corp.
 Chiron Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million. | Health Technology |
Bayer Plc
 Bayer Plc Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, Bayer Plc is a British company that markets and manufactures chemicals and those manufactured by Bayer AG and its subsidiaries. The company is based in Reading, UK. The company was founded in 1968. Lars Bruening has been the CEO of the company since 2017. | Commercial Services |
| Ciba Corning Diagnostics Corp. | |
| Boehringer Mannheim Canada Ltd. | |
| Flow Labss | |
| Advanced Medical Services, Inc. | |
L3 Technology Ltd.
L3 Technology Ltd. Miscellaneous Commercial ServicesCommercial Services L3 Technology Ltd. develops technology for cholesterol testing applications. The firm provides testing system for reading blood analytes from various samples. It offers a lipid profile testing system for measuring a multi-fraction lipid profile from a finger stick sample of blood, serum, or plasma. The company was founded in on June 28, 2001 and is headquartered in Sevenoaks, the United Kingdom. | Commercial Services |
